Hang Hu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Top Venues

Chemical biology & drug design

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Yongpeng Shen, Yilin Cheng, Haotian Hu, Yufeng Liu, Yujie Li, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates. Chemical biology & drug design 103 (3) (2024)
Jiangfei Liu, Yaohui Ni, Keyun Zhou, Guanzhao Wu, Liangyong Hu, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy. Chemical biology & drug design 104 (1) (2024)
Yongpeng Shen, Yilin Cheng, Haotian Hu, Yufeng Liu, Yujie Li, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates. Chemical biology & drug design 103 (3) (2024)
Shengping Liu, Fang Ding, Wei Xu, Liangrui Miu, Yuxiang Tang, Defeng Xu, Tianyu Zhu, Hang Hu
Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution. Chemical biology & drug design 103 (3) (2024)
Shengping Liu, Fang Ding, Wei Xu, Liangrui Miu, Yuxiang Tang, Defeng Xu, Tianyu Zhu, Hang Hu
Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution. Chemical biology & drug design 103 (3) (2024)
Xiaoyin Yuan, Yayu Tao, Wen Xiao, Kunda Du, Hang Hu, Defeng Xu, Qingbo Xu
Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells. Drug development research (2022)
Xinxin Cui, Kunda Du, Xiaoyin Yuan, Wen Xiao, Yayu Tao, Defeng Xu, Hang Hu
A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers. Drug development research (2021)